Plus, news about UK clinical studies and Kura Oncology:

Trevi Therapeutics to sell $150M in shares: The biotech plans to float more than 11.5 million shares at $13 apiece. Trevi is …

Subscribe for Updates

Copyright 2025 dijee Intelligence Ltd.   dijee Intelligence Ltd. is a private limited company registered in England and Wales at Media House, Sopers Road, Cuffley, Hertfordshire, EN6 4RY, UK registration number 16808844